Szarkóma: nyitott vizsgálatok itt: Kanada
38 trials · From ClinicalTrials.gov, checked 2026. nov. 10.. Ask the study team whether a trial fits you.
3. fázisToborozTrial-stage medicine
A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)
- Where
- Montreal
- Age
- 18 év and over
- People
- 400 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07541170EU 2025-524263-21-01Regiszter frissítve: 2026-11-09
3. fázisToborozTrial-stage medicine
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
- Where
- Calgary, Edmonton, Hamilton, Ottawa, Québec, Toronto, Vancouver, Winnipeg
- Age
- 18 év and over
- People
- 365 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06422806Regiszter frissítve: 2026-11-06
1/2. fázisToborozTrial-stage medicine
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
- Where
- Toronto
- Age
- 2 év to 30 év
- People
- 60 worldwide
- Run by
- Jazz Pharmaceuticals
See details and how to joinNCT05734066Regiszter frissítve: 2026-11-05
2. fázisToborozTrial-stage medicine
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Where
- Halifax, Montreal, Toronto
- Age
- 18 év and over
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT06760819EU 2024-517419-62-00Regiszter frissítve: 2026-11-04
No phaseToborozResearch participation
Activation Sarcoma: PROMIS and Mobility Evaluation in Sarcoma Patients
- Where
- Calgary, Toronto
- Age
- 18 év and over
- People
- 800 worldwide
- Run by
- University of Calgary
See details and how to joinNCT07227961Regiszter frissítve: 2026-11-02
1/2. fázisToborozTrial-stage medicine
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Calgary, Montreal, Toronto
- Age
- 6 hónap to 25 év
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103EU 2023-507178-41-00Regiszter frissítve: 2026-10-30
3. fázisToborozTrial-stage medicine
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
- Where
- Halifax, Hamilton, Montreal, Toronto, Trois-Rivières, Winnipeg
- Age
- 18 év and over
- People
- 348 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06345729EU 2023-507776-42-00Regiszter frissítve: 2026-10-26
1. fázisToborozTrial-stage medicine
GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours
- Where
- Calgary, Montreal, Ottawa, Toronto
- Age
- 15 év and over
- People
- 30
- Run by
- Canadian Cancer Trials Group
See details and how to joinNCT07297667Regiszter frissítve: 2026-10-16
2. fázisToborzás még nem indultTrial-stage medicine
Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled Trial
- Where
- Toronto
- Age
- 18 év and over
- People
- 46
- Run by
- University Health Network, Toronto
See details and how to joinNCT07820033Regiszter frissítve: 2026-10-15
No phaseToborozResearch participation
Evaluating the Use of Educational Videos in Newly Diagnosed Patients in a Medical Oncology Sarcoma Clinic
- Where
- Toronto
- Age
- 18 év and over
- People
- 100
- Run by
- Mount Sinai Hospital, Canada
See details and how to joinNCT06805773Regiszter frissítve: 2026-10-14
1. fázisToborozTrial-stage medicine
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
- Where
- Montreal
- Age
- 18 év and over
- People
- 180 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07261631Regiszter frissítve: 2026-10-09
3. fázisToborozTrial-stage medicine
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
- Where
- London, Montreal, Ottawa, Toronto, Vancouver
- Age
- 18 év and over
- People
- 250 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT04031677Regiszter frissítve: 2026-10-07
1/2. fázisToborozTrial-stage medicine
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Where
- Montreal
- Age
- Up to 30 év
- People
- 104 worldwide
- Run by
- Milton S. Hershey Medical Center
See details and how to joinNCT06541262Regiszter frissítve: 2026-10-06
1/2. fázisToborozTrial-stage medicine
A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)
- Where
- Montreal, Toronto
- People
- 64 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07602777Regiszter frissítve: 2026-10-01
1. fázisToborozTrial-stage medicine
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
- Where
- Toronto
- Age
- 18 év and over
- People
- 405 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06884618EU 2024-519622-20-00Regiszter frissítve: 2026-09-28
1/2. fázisToborozTrial-stage medicine
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Where
- Calgary, Edmonton, Montreal, Ottawa
- Age
- Up to 25 év
- People
- 75 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT04094610EU 2023-506464-14-00Regiszter frissítve: 2026-09-25
2. fázisToborozTrial-stage medicine
Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity
- Where
- Toronto, Vancouver
- Age
- 18 év and over
- People
- 50
- Run by
- British Columbia Cancer Agency
See details and how to joinNCT04273061Regiszter frissítve: 2026-09-16
3. fázisToborozResearch participation
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
- Where
- Calgary, Edmonton, Halifax, Montreal, Sherbrooke
- Age
- Up to 50 év
- People
- 62 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT05235165Regiszter frissítve: 2026-08-25
3. fázisToborozTrial-stage medicine
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
- Where
- Calgary, Edmonton, Halifax, Montreal, Québec, Sherbrooke, Toronto, Vancouver, Winnipeg
- Age
- Up to 21 év
- People
- 205 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT05304585Regiszter frissítve: 2026-08-25
3. fázisToborozTrial-stage medicine
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
- Where
- Montreal
- Age
- Up to 50 év
- People
- 342 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT07466316Regiszter frissítve: 2026-08-25
3. fázisToborozTrial-stage medicine
A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)
- Where
- Toronto
- Age
- 18 év and over
- People
- 333 worldwide
- Run by
- Intensity Therapeutics, Inc.
See details and how to joinNCT06263231EU 2024-512423-36-00Regiszter frissítve: 2026-08-11
No phaseToborozResearch participation
Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma
- Where
- Toronto
- Age
- 18 év and over
- People
- 100 worldwide
- Run by
- Australia and New Zealand Sarcoma Association
See details and how to joinNCT07377747Regiszter frissítve: 2026-07-15
No phaseToborozResearch participation
Circulating Tumor DNA in Soft Tissue Sarcoma
- Where
- Toronto
- Age
- 18 év and over
- People
- 40
- Run by
- University Health Network, Toronto
See details and how to joinNCT03818412Regiszter frissítve: 2026-06-23
2. fázisToborozTrial-stage medicine
A Trial of ABSK043, an Oral PD-L1 Inhibitor, in Patients With Angiogenic Sarcomas
- Where
- Toronto
- Age
- 18 év and over
- People
- 20
- Run by
- University Health Network, Toronto
See details and how to joinNCT07014137Regiszter frissítve: 2026-06-04
1/2. fázisToborozTrial-stage medicine
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
- Where
- Toronto, Vancouver
- Age
- 18 év and over
- People
- 252 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07223047Regiszter frissítve: 2026-05-28
Minden vizsgálat (Szarkóma) és a térkép
Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.